As FDA approval of the first postpartum depression drug hits the news, study looks at how infant fussiness and a baby's level of prematurity may influence the severity of maternal depressive symptoms.
from Latest Science News -- ScienceDaily https://ift.tt/2HSCFhe
via IFTTT
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment